An active tumor-targeting organic photochemotherapy agent via the combination of a an organic photothermal material and a naproxen prodrug was developed to precisely kill cancer cells and suppress the inflammatory response induced by cell necrosis; in vitro , and in vivo experiments illustrated its low cytotoxicity and excellent tumor inhibitory effect.